These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 32097819
1. Single-channel properties of skeletal muscle ryanodine receptor pore Δ4923FF4924 in two brothers with a lethal form of fetal akinesia. Xu L, Harms FL, Chirasani VR, Pasek DA, Kortüm F, Meinecke P, Dokholyan NV, Kutsche K, Meissner G. Cell Calcium; 2020 May; 87():102182. PubMed ID: 32097819 [Abstract] [Full Text] [Related]
3. Channel Gating Dependence on Pore Lining Helix Glycine Residues in Skeletal Muscle Ryanodine Receptor. Mei Y, Xu L, Mowrey DD, Mendez Giraldez R, Wang Y, Pasek DA, Dokholyan NV, Meissner G. J Biol Chem; 2015 Jul 10; 290(28):17535-45. PubMed ID: 25998124 [Abstract] [Full Text] [Related]
4. Single channel properties of heterotetrameric mutant RyR1 ion channels linked to core myopathies. Xu L, Wang Y, Yamaguchi N, Pasek DA, Meissner G. J Biol Chem; 2008 Mar 07; 283(10):6321-9. PubMed ID: 18171678 [Abstract] [Full Text] [Related]
5. A central core disease mutation in the Ca2+-binding site of skeletal muscle ryanodine receptor impairs single-channel regulation. Chirasani VR, Xu L, Addis HG, Pasek DA, Dokholyan NV, Meissner G, Yamaguchi N. Am J Physiol Cell Physiol; 2019 Aug 01; 317(2):C358-C365. PubMed ID: 31166712 [Abstract] [Full Text] [Related]
6. Ca2+-mediated activation of the skeletal-muscle ryanodine receptor ion channel. Xu L, Chirasani VR, Carter JS, Pasek DA, Dokholyan NV, Yamaguchi N, Meissner G. J Biol Chem; 2018 Dec 14; 293(50):19501-19509. PubMed ID: 30341173 [Abstract] [Full Text] [Related]
7. Muscle weakness in Ryr1I4895T/WT knock-in mice as a result of reduced ryanodine receptor Ca2+ ion permeation and release from the sarcoplasmic reticulum. Loy RE, Orynbayev M, Xu L, Andronache Z, Apostol S, Zvaritch E, MacLennan DH, Meissner G, Melzer W, Dirksen RT. J Gen Physiol; 2011 Jan 14; 137(1):43-57. PubMed ID: 21149547 [Abstract] [Full Text] [Related]
8. Clinical and functional effects of a deletion in a COOH-terminal lumenal loop of the skeletal muscle ryanodine receptor. Zorzato F, Yamaguchi N, Xu L, Meissner G, Müller CR, Pouliquin P, Muntoni F, Sewry C, Girard T, Treves S. Hum Mol Genet; 2003 Feb 15; 12(4):379-88. PubMed ID: 12566385 [Abstract] [Full Text] [Related]
9. Ion-pulling simulations provide insights into the mechanisms of channel opening of the skeletal muscle ryanodine receptor. Mowrey DD, Xu L, Mei Y, Pasek DA, Meissner G, Dokholyan NV. J Biol Chem; 2017 Aug 04; 292(31):12947-12958. PubMed ID: 28584051 [Abstract] [Full Text] [Related]
10. Structural and functional interactions between the Ca2+-, ATP-, and caffeine-binding sites of skeletal muscle ryanodine receptor (RyR1). Chirasani VR, Pasek DA, Meissner G. J Biol Chem; 2021 Sep 04; 297(3):101040. PubMed ID: 34352272 [Abstract] [Full Text] [Related]
11. Characterization of a calcium-regulation domain of the skeletal-muscle ryanodine receptor. Hayek SM, Zhu X, Bhat MB, Zhao J, Takeshima H, Valdivia HH, Ma J. Biochem J; 2000 Oct 01; 351(Pt 1):57-65. PubMed ID: 10998347 [Abstract] [Full Text] [Related]
12. Evidence for a role of the lumenal M3-M4 loop in skeletal muscle Ca(2+) release channel (ryanodine receptor) activity and conductance. Gao L, Balshaw D, Xu L, Tripathy A, Xin C, Meissner G. Biophys J; 2000 Aug 01; 79(2):828-40. PubMed ID: 10920015 [Abstract] [Full Text] [Related]
13. Homozygous/compound heterozygote RYR1 gene variants: Expanding the clinical spectrum. Alkhunaizi E, Shuster S, Shannon P, Siu VM, Darilek S, Mohila CA, Boissel S, Ellezam B, Fallet-Bianco C, Laberge AM, Zandberg J, Injeyan M, Hazrati LN, Hamdan F, Chitayat D. Am J Med Genet A; 2019 Mar 01; 179(3):386-396. PubMed ID: 30652412 [Abstract] [Full Text] [Related]
14. Ca(2+) inactivation sites are located in the COOH-terminal quarter of recombinant rabbit skeletal muscle Ca(2+) release channels (ryanodine receptors). Du GG, MacLennan DH. J Biol Chem; 1999 Sep 10; 274(37):26120-6. PubMed ID: 10473562 [Abstract] [Full Text] [Related]
15. Functional effects of central core disease mutations in the cytoplasmic region of the skeletal muscle ryanodine receptor. Avila G, Dirksen RT. J Gen Physiol; 2001 Sep 10; 118(3):277-90. PubMed ID: 11524458 [Abstract] [Full Text] [Related]
16. Functional and biochemical properties of ryanodine receptor type 1 channels from heterozygous R163C malignant hyperthermia-susceptible mice. Feng W, Barrientos GC, Cherednichenko G, Yang T, Padilla IT, Truong K, Allen PD, Lopez JR, Pessah IN. Mol Pharmacol; 2011 Mar 10; 79(3):420-31. PubMed ID: 21156754 [Abstract] [Full Text] [Related]
17. Malignant hyperthermia-associated mutations in the S2-S3 cytoplasmic loop of type 1 ryanodine receptor calcium channel impair calcium-dependent inactivation. Gomez AC, Holford TW, Yamaguchi N. Am J Physiol Cell Physiol; 2016 Nov 01; 311(5):C749-C757. PubMed ID: 27558158 [Abstract] [Full Text] [Related]
18. Dampened activity of ryanodine receptor channels in mutant skeletal muscle lacking TRIC-A. El-Ajouz S, Venturi E, Witschas K, Beech M, Wilson AD, Lindsay C, Eberhardt D, O'Brien F, Iida T, Nishi M, Takeshima H, Sitsapesan R. J Physiol; 2017 Jul 15; 595(14):4769-4784. PubMed ID: 28387457 [Abstract] [Full Text] [Related]
19. Role of amino-terminal half of the S4-S5 linker in type 1 ryanodine receptor (RyR1) channel gating. Murayama T, Kurebayashi N, Oba T, Oyamada H, Oguchi K, Sakurai T, Ogawa Y. J Biol Chem; 2011 Oct 14; 286(41):35571-35577. PubMed ID: 21862589 [Abstract] [Full Text] [Related]
20. Mutations to Gly2370, Gly2373 or Gly2375 in malignant hyperthermia domain 2 decrease caffeine and cresol sensitivity of the rabbit skeletal-muscle Ca2+-release channel (ryanodine receptor isoform 1). Du GG, Oyamada H, Khanna VK, MacLennan DH. Biochem J; 2001 Nov 15; 360(Pt 1):97-105. PubMed ID: 11695996 [Abstract] [Full Text] [Related] Page: [Next] [New Search]